candoxatril has been researched along with bumetanide in 1 studies
Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) | Studies (bumetanide) | Trials (bumetanide) | Recent Studies (post-2010) (bumetanide) |
---|---|---|---|---|---|
62 | 29 | 5 | 2,033 | 150 | 354 |
Protein | Taxonomy | candoxatril (IC50) | bumetanide (IC50) |
---|---|---|---|
Solute carrier family 12 member 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haloui, M; Louedec, L; Messika-Zeitoun, D; Michel, JB; Philippe, M | 1 |
1 other study(ies) available for candoxatril and bumetanide
Article | Year |
---|---|
Potentiation of urinary atrial natriuretic peptide interferes with macula densa function.
Topics: Animals; Atrial Natriuretic Factor; Bumetanide; Chlorides; Cyclic GMP; Diuresis; Epithelial Cells; Indans; Kidney Tubules, Distal; Male; NADPH Dehydrogenase; Neprilysin; Nitric Oxide Synthase; Potassium; Propionates; Proteins; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2001 |